# FDA 483 - Friese, David - November 02, 2021

Source: https://www.globalkeysolutions.net/records/483/friese-david/5d0cb988-113d-4523-aadb-7230d0f2241c

> FDA 483 for Friese, David on November 02, 2021. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Friese, David
- Inspection Date: 2021-11-02
- Product Type: veterinary
- Office Name: Minneapolis District Office
- Summary: During an inspection, David Friese was cited for administering a prohibited drug, sulfamenthazine, in an extralabel manner to lactating dairy cattle. Additionally, the firm failed to maintain adequate treatment records for animals, specifically lacking details on treated animals, dates, drugs, dosages, and withdrawal dates. These observations indicate significant deficiencies in animal drug management and record-keeping practices.

## Related Officers

- [Douglas J. Snyder](https://www.globalkeysolutions.net/people/douglas-j-snyder/d4fcec9d-230d-4481-a5e5-8ef7d0dbfdd2)
- [Investigator](https://www.globalkeysolutions.net/people/robert-j-waldorf/e8ef9c41-f6e4-4815-af0c-b2b4e04488b2)

Company: https://www.globalkeysolutions.net/companies/friese-david/bddc895f-5f65-4987-a66b-784744953ca5

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d